HORSHAM, Pa.; Nov. 8, 2021 – Clinical Ink — a global clinical trial data and technology company and leader in eSource and decentralized clinical trial conduct — today announced its acquisition of Digital Artefacts, a digital endpoint-based technology company with an unrivaled modular platform for complex cognitive, behavioral, and physiological data capture.
“Voice tasks can be thought of as a window by which one can see functionality of the human body that is not obvious by just looking at someone.
As new mobile and wearable technology continue to emerge, so do more objective methods and tools to measure patients and clinical trial participants.
Measuring the symptoms of movement disorders like Parkinson’s Disease, a neurological condition that affects the use of muscles (Mandal 2019), has always been challenging.
In the past decade, the technological possibilities with and ubiquity of consumer-grade wearables (or commercial off the shelf “COTS” devices) has drastically increased.
We recently sat down (virtually) with Dr. Leah Rubin from Johns Hopkins School of Medicine to discuss her work with BrainBaseline and BRACE (BrainBaseline Assessment of Cognition & Everyday Functioning) as well as her poster presentation at the AIDS 2020 Virtual Conference.
Cognitive impairment is increasingly recognized as a major side effect of cancer and its treatment.
BrainBaseline Lab is an iPad application that allows researchers and clinicians to configure a full neurocognitive battery.
BrainBaseline has enabled the self-administration of fully-digitized cognitive tests for over a decade.
